Aviance Capital Partners LLC Makes New Investment in The Clorox Company (NYSE:CLX)

Aviance Capital Partners LLC purchased a new position in shares of The Clorox Company (NYSE:CLX) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,000 shares of the company’s stock, valued at approximately $459,000.

Several other institutional investors also recently added to or reduced their stakes in CLX. Federated Hermes Inc. increased its position in Clorox by 16.4% during the third quarter. Federated Hermes Inc. now owns 4,744 shares of the company’s stock worth $622,000 after buying an additional 670 shares during the period. Bank of Nova Scotia increased its holdings in shares of Clorox by 237.7% in the third quarter. Bank of Nova Scotia now owns 36,232 shares of the company’s stock valued at $4,749,000 after purchasing an additional 25,502 shares during the period. Schonfeld Strategic Advisors LLC increased its holdings in shares of Clorox by 4,229.0% in the third quarter. Schonfeld Strategic Advisors LLC now owns 57,359 shares of the company’s stock valued at $7,517,000 after purchasing an additional 56,034 shares during the period. Lazard Asset Management LLC increased its holdings in shares of Clorox by 15.6% in the third quarter. Lazard Asset Management LLC now owns 151,534 shares of the company’s stock valued at $19,859,000 after purchasing an additional 20,398 shares during the period. Finally, AQR Capital Management LLC increased its holdings in shares of Clorox by 69.4% in the third quarter. AQR Capital Management LLC now owns 374,400 shares of the company’s stock valued at $48,253,000 after purchasing an additional 153,412 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on CLX shares. Barclays dropped their target price on Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a research report on Tuesday, March 26th. Evercore ISI decreased their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research report on Wednesday, May 1st. Wells Fargo & Company reduced their price objective on Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a research report on Thursday, May 2nd. Finally, Morgan Stanley restated an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a research report on Tuesday, March 26th. Five investment analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $145.33.

Clorox Trading Down 0.1 %

NYSE:CLX traded down $0.19 on Monday, hitting $136.28. 142,236 shares of the stock were exchanged, compared to its average volume of 1,256,667. The stock has a market cap of $16.92 billion, a PE ratio of 70.71, a PEG ratio of 2.19 and a beta of 0.39. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The stock has a fifty day moving average of $136.95 and a 200-day moving average of $143.79. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.14.

Clorox (NYSE:CLX) last issued its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the business earned $1.51 earnings per share. The company’s revenue was down 5.3% compared to the same quarter last year. As a group, equities analysts expect that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.